EFFECTIVENESS AND COST OF ECULIZUMAB ON PATIENTS WITH ATYPICAL (SHUA), URENIC AND HAEMOLITIC SYNDROME, WITH ENLARGEMENT OF THE FREQUENCY OF ADMINISTRATION
EFFECTIVENESS AND COST OF ECULIZUMAB ON PATIENTS WITH ATYPICAL (SHUA), URENIC AND HAEMOLITIC SYNDROME, WITH ENLARGEMENT OF THE FREQUENCY OF ADMINISTRATION